查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1789902

顯影劑市場規模、佔有率和趨勢分析報告：按方式、產品、應用、給藥途徑、最終用途、地區和細分市場預測，2025 年至 2033 年

Contrast Media Market Size, Share & Trends Analysis Report By Modality, By Product, By Application, By Route Of Administration, By End Use, By Region And Segment Forecasts, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

顯影劑市場摘要

2024 年全球顯影劑市場規模估計為 67.7 億美元，預計到 2033 年將達到 138.6 億美元，2025 年至 2033 年的複合年成長率為 8.33%。顯影劑的需求受到醫學影像診斷需求的不斷成長和慢性病負擔的增加所推動。

大量的診斷成像程序（例如超音波和 MRI 掃描）預計將支持市場成長。全球對醫學影像的需求不斷成長是推動顯影劑市場擴張的關鍵因素。醫學影像在各種健康狀況的早期發現、準確診斷和有效治療計劃中起著至關重要的作用。每年有數百萬患者接受 MRI、 電腦斷層掃描和 X 光等診斷程序。根據美國國家醫學圖書館於 2023 年 10 月發布的一項研究，光在美國每年就進行約 4,000 萬次 MRI 掃描。全球影像檢查的增加預計將顯著增加對顯影劑的需求，造影劑對於在這些測試期間增強身體內部結構的可視化至關重要。

美國以外國家對醫學影像的需求也在增加。根據澳洲健康與福利研究所 (AIHW) 2024 年 7 月發布的數據，2022-23 年總合1,020 萬澳洲人使用了醫療保險補貼的影像服務，約有 400 萬人使用了其他診斷服務。預計這一上升趨勢將持續下去，進一步推動全球對影像用造影顯影劑的需求成長。

此外，隨著診斷影像程序對可視化程度要求的不斷提高，碘顯影劑的需求也顯著成長。多種碘顯影劑的收益正在強勁成長，反映出其臨床應用的日益普及。例如，拜耳公司預計，Ultavist（一種基於碘溴的X光顯影劑，可用於動脈和靜脈注射）在2024年的收入將顯著成長。這種產品需求的激增凸顯了碘顯影劑在放射學領域的應用日益廣泛，並將成為全球顯影劑市場成長的關鍵驅動力。

钆顯影劑和碘基顯影劑之間豐富的分子結構推動了市場成長。這種多樣性使得能夠根據患者需求和臨床要求進行客製化的影像診斷，從而提高診斷的準確性和安全性。例如，钆基顯影劑廣泛應用於MRI，而碘基顯影劑則是CT的首選。持續研發安全性和有效性更高的先進顯影劑，進一步推動了腫瘤學、循環系統和神經病學等診斷應用領域的市場擴張。

下表列出了 MRI 和 CT 應用中常用的顯影劑及其品牌名稱和分子組成。

關鍵意見領袖（KOL）

公司名稱 KOL 成長機會

GE醫療集團藥物診斷業務全球研發主管保羅·埃文斯博士表示：“這款錳基造影劑的I期研究結果令人鼓舞，我們期待完成臨床開發流程的後續步驟。這是我們旨在改善患者全程治療顯影劑的產品平臺的一部分。”

  • 專注於臨床開發

費森尤斯卡比美國公司藥品行銷高級副總裁兼終止藥品短缺聯盟董事會主席林賽·托馬斯表示：「我們正在竭盡全力加快產品供應，包括空運，以幫助我們的客戶應對這一嚴重的顯影劑短缺問題。我們還在積極努力提供更多價格實惠的顯影劑，以幫助美國臨床醫生獲得必要的診斷學名藥組合。* 擴大製藥組合服務。* 擴大學名藥組合服務。

  • 解決供應鏈短缺問題
  • 對經濟實惠替代方案的需求不斷成長

GE醫療集團藥物診斷首席醫療官Mark Hibberd表示：「此次產品組合的擴展使我們能夠為眾多歐洲國家的客戶提供兩款領先的大環化合物——Clariscan（钆特酸）和Pixoscan（钆布醇），從而為他們的放射診斷需求提供更多選擇。我們將繼續創新並投資於我們的顯影劑

  • 利用大環化合物擴展投資組合

目錄

第1章調查方法與範圍

第2章執行摘要

第3章顯影劑市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 顯影劑市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章顯影劑市場：按模式類型的估計和趨勢分析

  • 細分儀表板
  • 全球顯影劑市場：按模式類型進行的變化分析
  • 全球顯影劑市場規模及趨勢分析（依模式類型，2021-2033）
  • 超音波
  • 磁振造影
  • X光/電腦斷層掃描

第5章顯影劑的估計和趨勢分析

  • 細分儀表板
  • 全球顯影劑市場產品波動分析
  • 全球顯影劑市場規模及趨勢分析（依產品，2021-2033）
  • 微氣泡
  • 钆基
  • 碘化
  • 鋇基

第6章顯影劑市場：按應用的估計和趨勢分析

  • 細分儀表板
  • 全球顯影劑市場波動分析（按應用）
  • 全球顯影劑市場規模及趨勢分析（按應用，2021-2033）
  • 心血管疾病
  • 神經系統疾病
  • 胃腸道疾病
  • 癌症
  • 腎臟疾病
  • 肌肉骨骼疾病
  • 其他

第7章顯影劑市場：按給藥途徑的估計和趨勢分析

  • 細分儀表板
  • 全球顯影劑市場依給藥途徑分析
  • 全球顯影劑市場規模及趨勢分析（依管理路線，2021-2033）
  • 靜脈
  • 口服途徑
  • 直腸途徑

第 8 章顯影劑設備：依最終用途的估算與趨勢分析

  • 細分儀表板
  • 全球顯影劑市場最終用途分析
  • 全球顯影劑市場規模與趨勢分析（依最終用途，2021-2033 年）
  • 醫院
    • 2021 年至 2033 年醫院市場估計與預測
  • 診斷影像中心
    • 2021 年至 2033 年診斷影像中心市場估計與預測
  • 其他
    • 2021年至2033年其他市場估計與預測

第9章顯影劑市場：區域估計和趨勢分析（按產品、方式、應用、給藥途徑和最終用途）

  • 區域儀表板
  • 2021-2033 年市場規模、預測與趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 印度
    • 中國
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
    • 創新者
  • 供應商格局
    • 主要經銷商和通路合作夥伴名單
    • Key customers
    • Global Key company market share analysis, 2024
    • Bayer AG
    • GE Healthcare
    • Beijing Beilu Pharmaceutical Co., Ltd.
    • Guerbet
    • Arco Lifesciences（I）Pvt. Ltd.
    • Livealth
    • JB Pharma
    • Blue Jet Healthcare.
    • Bracco Diagnostic, Inc.
    • Fresenius Kabi USA, LLC
    • Voyageur Pharmaceuticals, Ltd
    • Grupo Juste
    • Lantheus Holdings, Inc.
    • iMAX
    • Trivitron Healthcare
    • Jodas Expoim Pvt. Ltd.
  • 熱圖分析/企業市場分析
  • 2024年企業市場佔有率預測分析
  • 其他主要市場公司名單
Product Code: GVR-2-68038-357-7

Contrast Media Market Summary

The global contrast media market size was estimated at USD 6.77 billion in 2024 and is projected to reach USD 13.86 billion by 2033, growing at a CAGR of 8.33% from 2025 to 2033. The demand for contrast media is rising owing to the increasing demand for medical imaging and the growing burden of chronic disorders.

High volume of imaging procedures, such as ultrasound and MRI scans, performed is anticipated to support the market growth. The growing global demand for medical imaging is a key factor driving the expansion of the contrast media market. Medical imaging plays a crucial role in the early detection, accurate diagnosis, and effective treatment planning of various health conditions. Millions of patients undergo diagnostic procedures such as MRI, CT scans, and X-rays every year. According to a study published by the National Library of Medicine in October 2023, approximately 40 million MRI scans are performed annually in the U.S. alone. The increasing volume of imaging procedures worldwide is expected to significantly boost the demand for contrast media, essential for enhancing the visualization of internal body structures during these examinations.

Beyond the U.S., other countries are also experiencing a rising demand for medical imaging procedures. According to data published by the Australian Institute of Health & Welfare (AIHW) in July 2024, a total of 10.2 million Australians accessed Medicare-subsidized diagnostic imaging services in 2022-23, while approximately 4.0 million utilized other diagnostic services. This upward trend is expected to continue in the coming years, further contributing to the growing global demand for contrast media used in diagnostic imaging.

Furthermore, the demand for iodinated contrast media is rising significantly, driven by the growing number of imaging procedures requiring enhanced visualization. Several iodinated contrast agents are experiencing strong revenue growth, reflecting increased clinical adoption. For example, in 2024, Bayer AG reported a notable revenue increase from Ultravist, its iopromide-based X-ray contrast agent used for both intra-arterial and intravenous applications. This surge in product demand underscores the expanding utilization of iodinated contrast media in radiology, positioning them as a critical driver in the growth of the global contrast media market.

The availability of diverse molecular formulations among gadolinium-based and iodinated contrast agents drives market growth. This variety allows for tailored imaging based on patient needs and clinical requirements, enhancing diagnostic accuracy and safety. For instance, gadolinium agents are widely used in MRI applications, while iodinated agents are suitable for CT procedures. Continued R&D into advanced contrast media with improved safety and efficacy further supports market expansion across diagnostic applications like oncology, cardiology, and neurology.

The pictorial representation below highlights commonly used contrast agents in MRI and CT applications, along with their respective brand names and molecular compositions.

Key Opinion Leaders

Company Name KOLs Growth Opportunities

Dr Paul Evans, head of global R&D at GE HealthCare's Pharmaceutical Diagnostics business segment "These are encouraging Phase I results for this manganese-based contrast agent, and we look forward to completing the next steps in the clinical development process. This is part of our pipeline of products aiming to improve patient outcomes across care pathways." * Emerging Manganese-Based Contrast Agents

  • Focus on Clinical Development

Lindsey Thomas, senior vice president of Pharmaceutical Marketing at Fresenius Kabi USA and the company's representative on the End Drug Shortage Alliance Board of Directors "The U.S. availability of Iodixanol Injection, USP is the first offering from our generic radiology portfolio. We are doing everything we can to accelerate product availability to help our customers during this acute contrast media agent shortage, including air shipping product. We are also actively working to bring additional affordable contrast agents to U.S. clinicians to help ensure patient access to essential diagnostic imaging procedures." * Expansion of Generic Radiology Portfolio

  • Addressing Supply Chain Shortages
  • Growing Demand for Affordable Alternatives

Mark Hibberd, Chief Medical Officer, GE HealthCare Pharmaceutical Diagnostics "This extension to our portfolio means we will be able to offer two leading macrocyclic molecules-Clariscan (gadoteric acid) and Pixxoscan (gadobutrol)-to our customers in a number of European countries, offering radiology departments even more choice to suit their diagnostic needs. We continue to innovate and invest in our contrast media portfolio to deliver for healthcare professionals and patients and to meet future demand." * Geographic Market Penetration

  • Portfolio Expansion with Macrocyclic Molecules

Global Contrast Media Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global contrast media market report based on product, modality type, application, route of administration, end use, and region:

  • Modality Outlook (Revenue, USD Million, 2021-2033)
  • Ultrasound
  • Magnetic Resonance Imaging
  • X-ray/Computed Tomography
  • Product Outlook (Revenue, USD Million, 2021-2033)
  • Microbubble
  • Gadolinium-Based
  • Iodinated
  • Barium-Based
  • Application Outlook (Revenue, USD Million, 2021-2033)
  • Cardiovascular Disorders
  • Neurological Disorders
  • Gastrointestinal Disorders
  • Cancer
  • Nephrological Disorders
  • Musculoskeletal Disorders
  • Others
  • Route of Administration Outlook (Revenue, USD Million, 2021-2033)
  • Intravenous
  • Oral Route
  • Rectal Route
  • End Use Outlook (Revenue, USD Million, 2021-2033)
  • Hospitals
  • Diagnostic Imaging Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2021-2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Modality
    • 1.1.3. Application
    • 1.1.4. Route Of Administration
    • 1.1.5. End use
    • 1.1.6. Regional scope
    • 1.1.7. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Contrast Media Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing demand for medical imaging
      • 3.2.1.2. Approvals and launches of contrast media agents
      • 3.2.1.3. Increasing disease burden
      • 3.2.1.4. Technological advancements
      • 3.2.1.5. Rising production capacities for contrast media
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Recalls of contrast media
      • 3.2.2.2. Shortage of Iohexol and Iodixanol
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Development of interconnected solutions in contrast agents
      • 3.2.3.2. Growing number of clinical trials
      • 3.2.3.3. Improvements in public and private healthcare infrastructure
      • 3.2.3.4. Growth potential in emerging economies in contrast media market
    • 3.2.4. Market challenge analysis
      • 3.2.4.1. Potential complications and risks associated with contrast media
  • 3.3. Contrast Media Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Contrast Media Market: Modality Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Contrast Media Market Modality Type Movement Analysis
  • 4.3. Global Contrast Media Market Size & Trend Analysis, by Modality Type, 2021 to 2033 (USD Million)
  • 4.4. Ultrasound
    • 4.4.1. Ultrasound market estimates and forecasts for 2021 to 2033 (USD Million)
  • 4.5. Magnetic Resonance Imaging
    • 4.5.1. Magnetic resonance imaging market estimates and forecasts for 2021 to 2033 (USD Million)
  • 4.6. X-ray/Computed Tomography
    • 4.6.1. X-ray/computed tomography market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 5. Contrast Media Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Contrast Media Market Product Movement Analysis
  • 5.3. Global Contrast Media Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 5.4. Microbubble
    • 5.4.1. Microbubble market estimates and forecasts for 2021 to 2033 (USD Million)
  • 5.5. Gadolinium-Based
    • 5.5.1. Gadolinium-based market estimates and forecasts for 2021 to 2033 (USD Million)
  • 5.6. Iodinated
    • 5.6.1. Iodinated market estimates and forecasts for 2021 to 2033 (USD Million)
  • 5.7. Barium-based
    • 5.7.1. Barium-based market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 6. Contrast Media Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Contrast Media Market Application Movement Analysis
  • 6.3. Global Contrast Media Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Cardiovascular Disorders
    • 6.4.1. Cardiovascular disorders market estimates and forecast 2021 to 2033 (USD Million)
  • 6.5. Neurological Disorders
    • 6.5.1. Neurological disorders market estimates and forecast 2021 to 2033 (USD Million)
  • 6.6. Gastrointestinal Disorders
    • 6.6.1. Gastrointestinal disorders market estimates and forecast 2021 to 2033 (USD Million)
  • 6.7. Cancer
    • 6.7.1. Cancer market estimates and forecast 2021 to 2033 (USD Million)
  • 6.8. Nephrological Disorders
    • 6.8.1. Nephrological disorders market estimates and forecast 2021 to 2033 (USD Million)
  • 6.9. Musculoskeletal Disorders
    • 6.9.1. Musculoskeletal disorders market estimates and forecast 2021 to 2033 (USD Million)
  • 6.10. Others
    • 6.10.1. Others market estimates and forecast 2021 to 2033 (USD Million)

Chapter 7. Contrast Media Market: Route of Administration Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Contrast Media Market Route Of Administration Movement Analysis
  • 7.3. Global Contrast Media Market Size & Trend Analysis, by Route Of Administration, 2021 to 2033 (USD Million)
  • 7.4. Intravenous
    • 7.4.1. Intravenous market estimates and forecast 2021 to 2033 (USD Million)
  • 7.5. Oral Route
    • 7.5.1. Oral route market estimates and forecast 2021 to 2033 (USD Million)
  • 7.6. Rectal Route
    • 7.6.1. Rectal route market estimates and forecast 2021 to 2033 (USD Million)

Chapter 8. Contrast Media Devices: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global Contrast Media Market End Use Movement Analysis
  • 8.3. Global Contrast Media Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 8.4. Hospitals
    • 8.4.1. Hospitals market estimates and forecasts for 2021 to 2033 (USD Million)
  • 8.5. Diagnostic Imaging Centers
    • 8.5.1. Diagnostic imaging centers market estimates and forecasts for 2021 to 2033 (USD Million)
  • 8.6. Others
    • 8.6.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 9. Contrast Media Market: Regional Estimates & Trend Analysis By Product, By Modality, By Application, By Route of Administration, By End Use

  • 9.1. Regional Dashboard
  • 9.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 9.3. North America
    • 9.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Competitive scenario
      • 9.3.2.3. Regulatory framework
      • 9.3.2.4. Reimbursement scenario
      • 9.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
    • 9.3.3. Canada
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Competitive scenario
      • 9.3.3.3. Regulatory framework
      • 9.3.3.4. Reimbursement scenario
      • 9.3.3.5. Canada market estimates and forecasts, 2021 - 2033
    • 9.3.4. Mexico
      • 9.3.4.1. Key country dynamics
      • 9.3.4.2. Competitive scenario
      • 9.3.4.3. Regulatory framework
      • 9.3.4.4. Reimbursement scenario
      • 9.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
  • 9.4. Europe
    • 9.4.1. UK
      • 9.4.1.1. Key country dynamics
      • 9.4.1.2. Competitive scenario
      • 9.4.1.3. Regulatory framework
      • 9.4.1.4. Reimbursement scenario
      • 9.4.1.5. UK market estimates and forecasts, 2021 - 2033
    • 9.4.2. Germany
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Competitive scenario
      • 9.4.2.3. Regulatory framework
      • 9.4.2.4. Reimbursement scenario
      • 9.4.2.5. Germany market estimates and forecasts, 2021 - 2033
    • 9.4.3. France
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Competitive scenario
      • 9.4.3.3. Regulatory framework
      • 9.4.3.4. Reimbursement scenario
      • 9.4.3.5. France market estimates and forecasts, 2021 - 2033
    • 9.4.4. Italy
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Competitive scenario
      • 9.4.4.3. Regulatory framework
      • 9.4.4.4. Reimbursement scenario
      • 9.4.4.5. Italy market estimates and forecasts, 2021 - 2033
    • 9.4.5. Spain
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Competitive scenario
      • 9.4.5.3. Regulatory framework
      • 9.4.5.4. Reimbursement scenario
      • 9.4.5.5. Spain market estimates and forecasts, 2021 - 2033
    • 9.4.6. Denmark
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Competitive scenario
      • 9.4.6.3. Regulatory framework
      • 9.4.6.4. Reimbursement scenario
      • 9.4.6.5. Denmark market estimates and forecasts, 2021 - 2033
    • 9.4.7. Sweden
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. Competitive scenario
      • 9.4.7.3. Regulatory framework
      • 9.4.7.4. Reimbursement scenario
      • 9.4.7.5. Sweden market estimates and forecasts, 2021 - 2033
    • 9.4.8. Norway
      • 9.4.8.1. Key country dynamics
      • 9.4.8.2. Competitive scenario
      • 9.4.8.3. Regulatory framework
      • 9.4.8.4. Reimbursement scenario
      • 9.4.8.5. Norway market estimates and forecasts, 2021 - 2033
  • 9.5. Asia Pacific
    • 9.5.1. Japan
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Competitive scenario
      • 9.5.1.3. Regulatory framework
      • 9.5.1.4. Reimbursement scenario
      • 9.5.1.5. Japan market estimates and forecasts, 2021 - 2033
    • 9.5.2. India
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Competitive scenario
      • 9.5.2.3. Regulatory framework
      • 9.5.2.4. Reimbursement scenario
      • 9.5.2.5. India market estimates and forecasts, 2021 - 2033
    • 9.5.3. China
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Competitive scenario
      • 9.5.3.3. Regulatory framework
      • 9.5.3.4. Reimbursement scenario
      • 9.5.3.5. China market estimates and forecasts, 2021 - 2033
    • 9.5.4. South Korea
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Competitive scenario
      • 9.5.4.3. Regulatory framework
      • 9.5.4.4. Reimbursement scenario
      • 9.5.4.5. South Korea market estimates and forecasts, 2021 - 2033
    • 9.5.5. Australia
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Competitive scenario
      • 9.5.5.3. Regulatory framework
      • 9.5.5.4. Reimbursement scenario
      • 9.5.5.5. Australia market estimates and forecasts, 2021 - 2033
    • 9.5.6. Thailand
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Competitive scenario
      • 9.5.6.3. Regulatory framework
      • 9.5.6.4. Reimbursement scenario
      • 9.5.6.5. Thailand market estimates and forecasts, 2021 - 2033
  • 9.6. Latin America
    • 9.6.1. Brazil
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Competitive scenario
      • 9.6.1.3. Regulatory framework
      • 9.6.1.4. Reimbursement scenario
      • 9.6.1.5. Brazil market estimates and forecasts, 2021 - 2033
    • 9.6.2. Argentina
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Competitive scenario
      • 9.6.2.3. Regulatory framework
      • 9.6.2.4. Reimbursement scenario
      • 9.6.2.5. Argentina market estimates and forecasts, 2021 - 2033
  • 9.7. MEA
    • 9.7.1. South Africa
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Competitive scenario
      • 9.7.1.3. Regulatory framework
      • 9.7.1.4. Reimbursement scenario
      • 9.7.1.5. South Africa market estimates and forecasts, 2021 - 2033
    • 9.7.2. Saudi Arabia
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Competitive scenario
      • 9.7.2.3. Regulatory framework
      • 9.7.2.4. Reimbursement scenario
      • 9.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
    • 9.7.3. UAE
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Competitive scenario
      • 9.7.3.3. Regulatory framework
      • 9.7.3.4. Reimbursement scenario
      • 9.7.3.5. UAE market estimates and forecasts, 2021 - 2033
    • 9.7.4. Kuwait
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Competitive scenario
      • 9.7.4.3. Regulatory framework
      • 9.7.4.4. Reimbursement scenario
      • 9.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
    • 10.2.1. Innovators
  • 10.3. Vendor Landscape
    • 10.3.1. List of key distributors and channel partners
    • 10.3.2. Key customers
    • 10.3.3. Global Key company market share analysis, 2024
    • 10.3.4. Bayer AG
      • 10.3.4.1. Company overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Product benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. GE Healthcare
      • 10.3.5.1. Company overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Product benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. Beijing Beilu Pharmaceutical Co., Ltd.
      • 10.3.6.1. Company overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Product benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. Guerbet
      • 10.3.7.1. Company overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Product benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. Arco Lifesciences (I) Pvt. Ltd.
      • 10.3.8.1. Company overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Product benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. Livealth
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Product benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. JB Pharma
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Product benchmarking
      • 10.3.10.4. Strategic initiatives
    • 10.3.11. Blue Jet Healthcare.
      • 10.3.11.1. Company overview
      • 10.3.11.2. Financial performance
      • 10.3.11.3. Product benchmarking
      • 10.3.11.4. Strategic initiatives
    • 10.3.12. Bracco Diagnostic, Inc.
      • 10.3.12.1. Company overview
      • 10.3.12.2. Financial performance
      • 10.3.12.3. Product benchmarking
      • 10.3.12.4. Strategic initiatives
    • 10.3.13. Fresenius Kabi USA, LLC
      • 10.3.13.1. Company overview
      • 10.3.13.2. Financial performance
      • 10.3.13.3. Product benchmarking
      • 10.3.13.4. Strategic initiatives
    • 10.3.14. Voyageur Pharmaceuticals, Ltd
      • 10.3.14.1. Company overview
      • 10.3.14.2. Financial performance
      • 10.3.14.3. Product benchmarking
      • 10.3.14.4. Strategic initiatives
    • 10.3.15. Grupo Juste
      • 10.3.15.1. Company overview
      • 10.3.15.2. Financial performance
      • 10.3.15.3. Product benchmarking
      • 10.3.15.4. Strategic initiatives
    • 10.3.16. Lantheus Holdings, Inc.
      • 10.3.16.1. Company overview
      • 10.3.16.2. Financial performance
      • 10.3.16.3. Product benchmarking
      • 10.3.16.4. Strategic initiatives
    • 10.3.17. iMAX
      • 10.3.17.1. Company overview
      • 10.3.17.2. Financial performance
      • 10.3.17.3. Product benchmarking
      • 10.3.17.4. Strategic initiatives
    • 10.3.18. Trivitron Healthcare
      • 10.3.18.1. Company overview
      • 10.3.18.2. Financial performance
      • 10.3.18.3. Product benchmarking
      • 10.3.18.4. Strategic initiatives
    • 10.3.19. Jodas Expoim Pvt. Ltd.
      • 10.3.19.1. Company overview
      • 10.3.19.2. Financial performance
      • 10.3.19.3. Product benchmarking
      • 10.3.19.4. Strategic initiatives
  • 10.4. Heat Map Analysis/ Company Market Position Analysis
  • 10.5. Estimated Company Market Share Analysis, 2024
  • 10.6. List of Other Key Market Players

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. North America contrast media market, by country, 2021 - 2033 (USD Million)
  • Table 4. North America contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 5. North America contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 6. North America contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 7. North America contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 8. North America contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 9. U.S. contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 10. U.S. contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 11. U.S. contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 12. U.S. contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 13. U.S. contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 14. Canada contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 15. Canada contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 16. Canada contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 17. Canada contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 18. Canada contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 19. Mexico contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 20. Mexico contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 21. Mexico contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 22. Mexico contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 23. Mexico contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 24. Europe contrast media market, by country, 2021 - 2033 (USD Million)
  • Table 25. Europe contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 26. Europe contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 27. Europe contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 28. Europe contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 29. Europe contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 30. UK contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 31. UK contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 32. UK contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 33. UK contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 34. UK contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 35. Germany contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 36. Germany contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 37. Germany contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 38. Germany contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 39. Germany contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 40. France contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 41. France contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 42. France contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 43. France contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 44. France contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 45. Italy contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 46. Italy contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 47. Italy contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 48. Italy contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 49. Italy contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 50. Spain contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 51. Spain contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 52. Spain contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 53. Spain contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 54. Spain contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 55. Denmark contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 56. Denmark contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 57. Denmark contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 58. Denmark contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 59. Denmark contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 60. Sweden contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 61. Sweden contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 62. Sweden contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 63. Sweden contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 64. Sweden contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 65. Norway contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 66. Norway contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 67. Norway contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 68. Norway contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 69. Norway contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 70. Asia Pacific contrast media market, by country, 2021 - 2033 (USD Million)
  • Table 71. Asia Pacific contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 72. Asia Pacific contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 73. Asia Pacific contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 74. Asia Pacific contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 75. Asia Pacific contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 76. China contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 77. China contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 78. China contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 79. China contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 80. China contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 81. Japan contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 82. Japan contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 83. Japan contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 84. Japan contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 85. Japan contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 86. India contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 87. India contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 88. India contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 89. India contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 90. India contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 91. South Korea contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 92. South Korea contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 93. South Korea contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 94. South Korea contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 95. South Korea contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 96. Australia contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 97. Australia contrast media market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 98. Australia contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 99. Australia contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 100. Australia contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 101. Thailand contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 102. Thailand contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 103. Thailand contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 104. Thailand contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 105. Thailand contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 106. Latin America contrast media market, by country, 2021 - 2033 (USD Million)
  • Table 107. Latin America contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 108. Latin America contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 109. Latin America contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 110. Latin America contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 111. Latin America contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 112. Brazil contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 113. Brazil contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 114. Brazil contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 115. Brazil contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 116. Brazil contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 117. Argentina contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 118. Argentina contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 119. Argentina contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 120. Argentina contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 121. Argentina contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 122. Middle East & Africa contrast media market, by country, 2021 - 2033 (USD Million)
  • Table 123. Middle East & Africa contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 124. Middle East & Africa contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 125. Middle East & Africa contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 126. Middle East & Africa contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 127. Middle East & Africa contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 128. South Africa contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 129. South Africa contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 130. South Africa contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 131. South Africa contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 132. South Africa contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 133. Saudi Arabia contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 134. Saudi Arabia contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 135. Saudi Arabia contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 136. Saudi Arabia contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 137. Saudi Arabia contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 138. UAE contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 139. UAE contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 140. UAE contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 141. UAE contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 142. UAE contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 143. Kuwait contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 144. Kuwait contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 145. Kuwait contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 146. Kuwait contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 147. Kuwait contrast media market, by application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Contrast Media Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Contrast media market: Modality movement analysis
  • Fig. 15 Ultrasound Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 16 Magnetic Resonance Imaging Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 17 X-Ray/Computed Tomography Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 18 Contrast Media Market: Product Movement Analysis
  • Fig. 19 Microbubble Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Gadolinium-Based Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Iodinated Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Barium-Based Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Contrast Media Market: Application Movement Analysis
  • Fig. 24 Cardiovascular Disorders Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Neurological Disorders Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Cancer Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 27 Gastrointestinal Disorders Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 28 Nephrological Disorders Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 29 Musculoskeletal Disorders Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Gastrointestinal Disorders Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Contrast Media Market: Route Of Administration Movement Analysis
  • Fig. 32 Intravenous Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 33 Oral Route Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 34 Rectal Route Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 35 Contrast Media Market: End Use Movement Analysis
  • Fig. 36 Hospitals Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Diagnostic Imaging Centers Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 38 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 39 Regional Outlook, 2024 & 2033
  • Fig. 40 North America Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 41 U.S. Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 42 Canada Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 43 Mexico Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 44 Europe Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 45 Germany Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 46 UK Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 47 France Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 48 Italy Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 49 Spain Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 50 Denmark Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 51 Sweden Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 52 Norway Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 53 Asia Pacific Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 54 Japan Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 55 China Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 56 India Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 57 Australia Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 58 South Korea Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 59 Thailand Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 60 Latin America Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 61 Brazil Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 62 Argentina Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 63 Middle East and Africa Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 64 South Africa Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 65 Saudi Arabia Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 66 UAE Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 67 Kuwait Contrast Media Market, 2021 - 2033 (USD Million)